WallStreetZenWallStreetZen

NASDAQ: BLPH
Bellerophon Therapeutics Inc Stock Ownership - Who owns Bellerophon Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Bellerophon Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bobae KimVP Reg. Affairs Quality2023-05-18266$7.35
$1.96kBuy
Bobae KimVP Reg. Affairs Quality2023-05-189,455$10.00
$94.55kSell
Puissance Life Science Opportunities Fund Vi10% Owner2023-05-18560,000$9.46
$5.30MSell
Bobae KimVP Reg. Affairs Quality2023-05-181,022$7.50
$7.67kBuy
Parag Suresh ShahVP OF BUSINESS OPERATIONS2022-12-097,834$0.93
$7.29kSell
Peter FernandesPRINCIPAL EXECUTIVE OFFICER2022-12-099,985$0.93
$9.29kSell
Nicholas LacconaFINANCIAL OFFICER PFO PAO2022-12-095,530$0.93
$5.14kSell
Martin DekkerVP OF ENGINEERING MANUFACTUR2022-12-097,834$0.93
$7.29kSell

1 of 1

BLPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BLPH insiders and whales buy or sell their stock.

BLPH Shareholders

What type of owners hold Bellerophon Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Theodore T. Wang80.00%8,359,668$59.02MInsider
Puissance Crossborder Opportunities Iii LLC79.42%8,298,755$58.59MInsider
Venrock Associates Iv L P61.58%6,435,173$45.43MInsider
Linde North America Inc50.45%5,271,796$37.22MInsider
Adam Weinstein46.91%4,902,015$34.61MInsider
Matthew S. Holt46.68%4,878,117$34.44MInsider
Jens Luehring34.88%3,645,017$25.73MInsider
Robert Nelsen16.45%1,718,654$12.13MInsider
Puissance Life Science Opportunities Fund Vi11.59%1,211,262$8.55MInsider
Arch Venture Fund Vi LP9.24%965,660$6.82MInsider

1 of 3

BLPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLPH6.87%93.13%Net SellingNet Selling
PIRS41.76%5.69%Net BuyingNet Buying
CRDF15.78%34.48%Net Buying
MDWD23.65%0.00%
FBIO21.31%32.84%Net Buying
View Top Biotech Stocks

Bellerophon Therapeutics Stock Ownership FAQ

Who owns Bellerophon Therapeutics?

Bellerophon Therapeutics (NASDAQ: BLPH) is owned by 33.81% institutional shareholders, 458.14% Bellerophon Therapeutics insiders, and 0.00% retail investors. Theodore T. Wang is the largest individual Bellerophon Therapeutics shareholder, owning 8.36M shares representing 80.00% of the company. Theodore T. Wang's Bellerophon Therapeutics shares are currently valued at $59.02M.

If you're new to stock investing, here's how to buy Bellerophon Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.